Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cue Biopharma Inc (NQ: CUE ) 0.7401 +0.0191 (+2.65%) Streaming Delayed Price Updated: 9:49 AM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Cue Biopharma Inc < Previous 1 2 Next > Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights August 19, 2024 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma to Host Business Update Call and Webcast August 13, 2024 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma Announces Strategic Prioritization of Autoimmune Programs Enabling Optimization of Workforce and Reduction of Capital Requirements July 25, 2024 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma Inc. (NASDAQ: CUE) Leading the Way in Wednesday Trading Based on Percentage Gain March 13, 2024 Via Investor Brand Network Cue Biopharma Presents Updated Data from Phase 1 Trial of CUE-101 in Recurrent/Metastatic HPV+ Head and Neck Cancer at the 2024 ASCO Annual Meeting June 04, 2024 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in June 2024 June 03, 2024 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights May 09, 2024 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma to Present at the 20th Annual PEGS Boston Summit May 08, 2024 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences Conference May 07, 2024 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting April 24, 2024 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights April 08, 2024 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma to Host Business Update Call and Webcast April 02, 2024 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium February 29, 2024 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma to Present Corporate Update at the Oppenheimer 34th Annual Healthcare Life Sciences Conference February 06, 2024 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma to Present at the JMP Securities Hematology and Oncology Summit November 22, 2023 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights November 09, 2023 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma to Present at Three Upcoming Investor Healthcare Conferences in November November 07, 2023 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma Presents New Positive Data from Phase 1 Trials of CUE-101 in Head and Neck Cancer and CUE-102 in Wilms’ Tumor 1 Positive Cancers at SITC 2023 November 03, 2023 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma to Host Business Update Call and Webcast November 02, 2023 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting September 27, 2023 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma Announces Completion of Patient Enrollment in Phase 1b Study of CUE-101 in Combination with KEYTRUDA® September 26, 2023 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma Reports Second Quarter 2023 Financial Results and Recent Business Highlights August 09, 2023 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma to Host Business Update Call and Webcast August 02, 2023 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma to Present at the Federation of Clinical Immunology Societies (FOCIS) 2023 Annual Meeting June 14, 2023 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma to Host Investor Call June 07, 2023 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma to Present at the Jefferies 2023 Global Healthcare Conference June 05, 2023 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma Presents Positive Data Update from Ongoing Phase 1 Trials of CUE-101 for Recurrent/Metastatic HPV+ Head and Neck Squamous Cell Carcinoma at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting May 25, 2023 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma to Present at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting May 15, 2023 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma Reports First Quarter 2023 Financial Results and Recent Business Highlights May 09, 2023 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma to Present at the Upcoming JMP Securities Life Sciences Conference May 08, 2023 From Cue Biopharma, Inc. Via GlobeNewswire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
